1. Home
  2. POAI vs GTBP Comparison

POAI vs GTBP Comparison

Compare POAI & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • GTBP
  • Stock Information
  • Founded
  • POAI 2002
  • GTBP 1965
  • Country
  • POAI United States
  • GTBP United States
  • Employees
  • POAI N/A
  • GTBP N/A
  • Industry
  • POAI Industrial Specialties
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • POAI Health Care
  • GTBP Health Care
  • Exchange
  • POAI Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • POAI 9.7M
  • GTBP 4.9M
  • IPO Year
  • POAI N/A
  • GTBP N/A
  • Fundamental
  • Price
  • POAI $1.46
  • GTBP $2.15
  • Analyst Decision
  • POAI Hold
  • GTBP Strong Buy
  • Analyst Count
  • POAI 1
  • GTBP 1
  • Target Price
  • POAI N/A
  • GTBP $11.00
  • AVG Volume (30 Days)
  • POAI 2.8M
  • GTBP 238.1K
  • Earning Date
  • POAI 03-27-2025
  • GTBP 03-25-2025
  • Dividend Yield
  • POAI N/A
  • GTBP N/A
  • EPS Growth
  • POAI N/A
  • GTBP N/A
  • EPS
  • POAI N/A
  • GTBP N/A
  • Revenue
  • POAI $1,484,223.00
  • GTBP N/A
  • Revenue This Year
  • POAI N/A
  • GTBP N/A
  • Revenue Next Year
  • POAI $569.48
  • GTBP N/A
  • P/E Ratio
  • POAI N/A
  • GTBP N/A
  • Revenue Growth
  • POAI N/A
  • GTBP N/A
  • 52 Week Low
  • POAI $0.55
  • GTBP $1.72
  • 52 Week High
  • POAI $3.76
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • POAI 59.80
  • GTBP 42.94
  • Support Level
  • POAI $1.36
  • GTBP $2.10
  • Resistance Level
  • POAI $1.58
  • GTBP $2.39
  • Average True Range (ATR)
  • POAI 0.21
  • GTBP 0.21
  • MACD
  • POAI -0.01
  • GTBP 0.01
  • Stochastic Oscillator
  • POAI 30.58
  • GTBP 36.00

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: